Announcement on Voluntary Disclosure of Positive Preliminary Results of the Phase Ib Clinical Study of the Innovative Drug SGC001 of the Joint-stock Company
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment